Press Releases

LEUKOCARE announces EUR 3.4 M capital increase

LEUKOCARE in collaboration with Technical University Munich (TUM) develops a novel HBV vaccine and receives grant by German government

2012LEUKOCARE licenses biomarker cell-free DNA to Trillium Diagnostics

LEUKOCARE to publish scientific findings and background of its SPS®-technology in Materials Today

LEUKOCARE provides key technologies for tumour diagnosis in personalized medicine research project

LEUKOCARE to receive Frost & Sullivan’s prestigious 2011 Biotechnology Investment Opportunity Award

LEUKOCARE´s QM System Passes Surveillance Audit Successfully

German Ministry of Economics Grants Nonrefundable Subsidies to LEUKOCARE for Development of Functional Coatings in Orthopedic Implants

Sanofi-Pasteur evaluates LEUKOCARE’s SPS® technology for vaccine stabilization

LEUKOCARE signs cooperation agreement with Sterigenics